JPS62289520A - エリスロマイシン塩基含有抗アクネ安定組成物 - Google Patents

エリスロマイシン塩基含有抗アクネ安定組成物

Info

Publication number
JPS62289520A
JPS62289520A JP62094262A JP9426287A JPS62289520A JP S62289520 A JPS62289520 A JP S62289520A JP 62094262 A JP62094262 A JP 62094262A JP 9426287 A JP9426287 A JP 9426287A JP S62289520 A JPS62289520 A JP S62289520A
Authority
JP
Japan
Prior art keywords
erythromycin
composition according
acne
monomethyl ether
propylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62094262A
Other languages
English (en)
Japanese (ja)
Inventor
ジャン−ピエール・ロージェ
ベアトリス・ルノール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of JPS62289520A publication Critical patent/JPS62289520A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
JP62094262A 1986-04-16 1987-04-15 エリスロマイシン塩基含有抗アクネ安定組成物 Pending JPS62289520A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU86393A LU86393A1 (fr) 1986-04-16 1986-04-16 Composition anti-acneique stable a base d'erythromycine
LU86393 1986-04-16

Publications (1)

Publication Number Publication Date
JPS62289520A true JPS62289520A (ja) 1987-12-16

Family

ID=19730682

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62094262A Pending JPS62289520A (ja) 1986-04-16 1987-04-15 エリスロマイシン塩基含有抗アクネ安定組成物

Country Status (8)

Country Link
JP (1) JPS62289520A (fr)
BE (1) BE1000153A4 (fr)
CH (1) CH670567A5 (fr)
DE (1) DE3712758C2 (fr)
FR (1) FR2597342B1 (fr)
GB (1) GB2189392B (fr)
IT (1) IT1206778B (fr)
LU (1) LU86393A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006056897A (ja) * 1996-09-19 2006-03-02 Merial Sas 殺寄生虫薬の新規な組み合せ

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133800A (en) * 1966-11-10 1968-11-20 Ici Ltd Pharmaceutical compositions
US4000263A (en) * 1975-05-02 1976-12-28 Westwood Pharmaceuticals, Inc. Erythromycin solution
FR2368949A1 (fr) * 1976-11-01 1978-05-26 Procter & Gamble Produit antimicrobien a base d'erythromycine pour le traitement topique des affections acneiques
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
BE863935A (fr) * 1977-02-26 1978-08-14 Basf Ag Utilisation de l'ether 1,2-propylene-glycol-1-n-propylique comme solvant pour preparations pharmaceutiques
US4261982A (en) * 1977-11-09 1981-04-14 The Procter & Gamble Company Therapeutic composition
CA1165240A (fr) * 1980-07-09 1984-04-10 The Procter & Gamble Company Composes pharmaceutiques a usage topique
AU549271B2 (en) * 1981-11-27 1986-01-23 Pitman-Moore Australia Limited Levamisole composition
EP0095813A3 (fr) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Compositions pharmaceutiques topiques pénétrantes contenant la 9-(2-hydroxyéthoxyméthyl)-guanine
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006056897A (ja) * 1996-09-19 2006-03-02 Merial Sas 殺寄生虫薬の新規な組み合せ

Also Published As

Publication number Publication date
LU86393A1 (fr) 1987-12-07
IT1206778B (it) 1989-05-03
FR2597342B1 (fr) 1990-05-18
CH670567A5 (fr) 1989-06-30
GB8709017D0 (en) 1987-05-20
DE3712758C2 (de) 1997-09-25
FR2597342A1 (fr) 1987-10-23
GB2189392B (en) 1990-02-14
IT8720140A0 (it) 1987-04-15
GB2189392A (en) 1987-10-28
BE1000153A4 (fr) 1988-05-31
DE3712758A1 (de) 1987-10-22

Similar Documents

Publication Publication Date Title
CA1124179A (fr) Methode de traitement de l'acne et compose utilise a cette fin
US5690923A (en) Stable topical retinoid compositions
CA1307207C (fr) Lotion a base de steroides
US4657901A (en) Pharmaceutical composition
CA1279576C (fr) Traitement des troubles de la peau
US4794106A (en) Cream
NO971951L (no) Farmasöytiske preparater
KR920021139A (ko) 약학 조성물
US5767161A (en) Pharmaceutical compositions for topical use containing (S)-2-(4-isobutylphenyl) propinonic acid
JPS58208214A (ja) 座瘡の局所処置用の薬学調製剤
JPH0729929B2 (ja) ハイドロコ−チゾンジエステルを含有するクリ−ム
JPH0217122A (ja) 皮膚疾患の処置
KR20000049125A (ko) 외용 국소 마취제
US20230037905A1 (en) Topical composition comprising tofacitinib and fingolimod
CA2310049C (fr) Utilisation d'un melange de diol et d'acide alpha-hydroxyle pour traiter des hyperkeratoses
JPS62289520A (ja) エリスロマイシン塩基含有抗アクネ安定組成物
DE69001734T2 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
CS275816B6 (en) Cosmetic preparation for use on greasy skin
KR950003611B1 (ko) 항진균 외용 이미다졸 제제
WO2014090859A1 (fr) Compositions de gel
US3524916A (en) Griseofulvin-ethylene glycol monosalicylate compositions
US5696099A (en) Topical preparations for the treatment of acne and acneiform dermatitis
HK1007104B (en) Antimycotic external imidazole preparations
US20230320984A1 (en) Tofacitinib-containing anhydrous elastomer-based gel formulations
JP2522482B2 (ja) 養毛剤